Methods for Treatment of Malignant Pleural Effusion

被引:0
|
作者
Charyshkin, Alexei L. [1 ]
Kuzmina, Ekaterina A. [2 ]
Khusnutdinov, Bulat, I [1 ,3 ]
Toneev, Evgeniy A. [1 ,3 ]
Midlenko, Vladimir, I [1 ]
机构
[1] Ulyanovsk State Univ, Ulyanovsk, Russia
[2] Pirogov Russian Natl Res Med Univ, Moscow, Russia
[3] Reg Clin Oncol Ctr, Ulyanovsk, Russia
关键词
malignant pleural effusions; thoracentesis; pleurodesis; indwelling pleural catheters; PROGNOSTIC-FACTORS; TALC PLEURODESIS; MANAGEMENT; SURVIVAL; EFFICACY; SAFETY; THORACENTESIS; CATHETERS; ALGORITHM; POUDRAGE;
D O I
10.21103/Article10(1)_RA2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This brief review provides up-to-date information on the management of malignant pleural effusions (MPE). In general, selection of the most appropriate treatment approach should be individualized. Management of MPE relies on tumor type, pulmonary re-expansion, performance status, symptoms, and life expectancy. Pleurodesis and IPC placement are two effective treatments recommended for recurrent MPE, both of which can effectively improve dyspnea and quality of life of patients. Other options such as intrapleural therapies, radiation therapy, and pleuroperitoneal shunting are alternative treatments. However, most of these treatments are temporary, and MPE would recur soon. Hence, further palliative treatments to effectively control pleural effusions and relieve symptoms are necessary.
引用
收藏
页码:16 / 19
页数:4
相关论文
共 50 条
  • [31] Ambulatory treatment of malignant pleural effusion: A case report
    Cano Hoz, Marta
    Priede Diaz, Luis
    Carrascosa Porras, Miguel
    MEDICINA PALIATIVA, 2012, 19 (01) : 3 - 9
  • [32] The Clinical and Economic Implications of Different Treatment Pathways for Patients With Rapidly Recurrent Malignant Pleural Effusion
    Ost, David E.
    Goldblatt, Claudia
    Jung, Molly
    Weiss, Mia
    Xu, Shibei
    Taneja, Ashley
    Erdal, Erik
    CHEST, 2024, 166 (04) : 867 - 881
  • [33] Managing malignant pleural effusion with an indwelling pleural catheter: factors associated with spontaneous pleurodesis
    Wong, W. M.
    Tam, Terence C. C.
    Wong, Matthew K. Y.
    Lui, Macy M. S.
    Ip, Mary S. M.
    Lam, David C. L.
    HONG KONG MEDICAL JOURNAL, 2016, 22 (04) : 334 - 340
  • [34] Adverse events after pleurodesis in patients with malignant pleural effusion
    Terra, Ricardo Mingarini
    da Costa, Priscila Berenice
    Dela Vega, Alberto Jorge Monteiro
    Pego-Fernandes, Paulo Manuel
    JOURNAL OF THORACIC DISEASE, 2020, 12 (07) : 3507 - 3513
  • [35] Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion
    Shi, Xin-Yu
    Yi, Feng-Shuang
    Wang, Zheng
    Qiao, Xin
    Zhai, Kan
    THORACIC CANCER, 2020, 11 (02) : 320 - 328
  • [36] Diagnosis and Treatment of Malignant Pleural Effusion A Systematic Literature Review and New Approaches
    Lombardi, Giuseppe
    Zustovich, Fable
    Nicoletto, Maria Ornella
    Donach, Martin
    Artioli, Grazia
    Pastorelli, Davide
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (04): : 420 - 423
  • [37] Malignant pleural effusion: from bench to bedside
    Psallidas, Ioannis
    Kalomenidis, Ioannis
    Porcel, Jose M.
    Robinson, Bruce W.
    Stathopoulos, Georgios T.
    EUROPEAN RESPIRATORY REVIEW, 2016, 25 (140) : 189 - 198
  • [38] Management of malignant pleural effusion: challenges and solutions
    Penz, Erika
    Watt, Kristina N.
    Hergott, Christopher A.
    Rahman, Najib M.
    Psallidas, Ioannis
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 229 - 241
  • [39] Validating LENT score in malignant pleural effusion
    Alawneh, Alia
    Farsakh, Fadi Abu
    Smadi, Mahmoud
    Samrah, Shaher
    FUTURE SCIENCE OA, 2024, 10 (01):
  • [40] Management of Malignant Pleural Effusion
    Kastelik, Jack A.
    LUNG, 2013, 191 (02) : 165 - 175